Physician profile
Benzi Estipona
NPI 1972248540
$4,756.41
in general payments reported to CMS, 2019-2025
12 companies · $1,402 in 2025
The $1,402 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $342 · 2023: $2,374 · 2024: $638 · 2025: $1,402.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,040 · Travel and Lodging: $1,424 · Education: $950.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,039.83 |
| Travel and Lodging | $1,423.64 |
| Education | $950.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $3,081.98 | 2022-2025 | Actis, Va-Lcp |
| Zimmer Biomet Holdings, INC. | $349.47 | 2023-2025 | Persona, Xtrafix |
| Depuy Synthes Sales INC. | $238.20 | 2023 | Actis, Na, Velys |
| Medtronic, INC. | $171.06 | 2025 | Mazor X System |
| Stryker Corporation | $167.08 | 2025 | Pangea |
| Davol INC. | $166.49 | 2025 | Arista |
| Skeletal Dynamics INC | $131.46 | 2024 | Align, Geminus, Ijs |
| Endo USA, INC. | $125.73 | 2025 | Xiaflex |
| Osteocentric Technologies, INC. | $115.78 | 2025 | Osteocentric 4.0 X 130mm Locking Bone Screw Fastener St |
| Innovation Technologies INC | $113.33 | 2024 | Irrisept |
| Integra Lifesciences Corporation | $71.69 | 2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Lifenet Health | $24.14 | 2025 | Graftlink |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benzi Estipona listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.